Workflow
上市4日,大涨99%!

Market Overview - On October 6, the Hong Kong stock market opened lower and continued to decline, with the Hang Seng Index down 0.61% to 26,976.52 points, the Hang Seng China Enterprises Index down 0.85% to 9,576.22 points, and the Hang Seng Tech Index down 1.20% to 6,543.62 points [1] Sector Performance - The gold and precious metals, mining, industrial engineering, and insurance sectors showed strength, while the real estate, oil and gas, and utilities sectors remained active. The information technology, food and beverage, and telecommunications sectors led the decline [2] - The gold and precious metals sector in Hong Kong saw significant gains, with China Silver Group rising over 18%, Hong Kong Silver Holdings up over 15%, and Zijin Mining International increasing over 5% [3] Gold Market Insights - International gold prices reached a new historical high, surpassing $3,900 per ounce, just days after breaking the $3,800 per ounce mark [4] - The recent surge in gold prices is driven by three main factors: increased global risk aversion, ongoing expectations of interest rate cuts by the Federal Reserve, and a sustained trend of central bank gold purchases [4] Company Highlights - Zijin Mining International, which focuses on overseas gold asset integration, has seen its stock price nearly double since its listing on September 30, with a cumulative increase of 99.19% [4] - Zijin Mining International holds gold reserves of 856 tons, ranking ninth globally, and has a production capacity of 40.4 tons, ranking eleventh globally [4] - Huahong Semiconductor's stock price rose over 6% on October 6, reaching a new historical high, with a closing price of HKD 91.90 per share and a trading volume exceeding HKD 1.3 billion [5][6] - Goldman Sachs raised the target price for Huahong Semiconductor to HKD 117 per share, citing opportunities in the expanding AI ecosystem in China [7] Individual Stock Movements - Dingdang Health's stock surged by 34% during the trading session, closing up 26.8% at HKD 1.23 per share, driven by its ongoing innovation in drug offerings [8][10]